Walleye Trading’s Verona Pharma VRNA Stock Holding History

Walleye Trading’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-112,700	Closed	-$12M	–	4867
2025 Q3	$12M	Buy	112,700 +107,900	+2,248%	+$11.3M	0.02%	810
2025 Q2	$454K	Buy	4,800 +800	+20%	+$59.2K	﹤0.01%	2712
2025 Q1	$254K	Buy	4,000 +300	+8%	+$17.9K	﹤0.01%	2944
2024 Q4	$172K	Buy	+3,700	New	+$139K	﹤0.01%	3302
2024 Q1	–	Sell	-1,100	Closed	-$21.9K	–	5411
2023 Q4	$21.9K	Sell	1,100 -200	-15%	-$2.95K	﹤0.01%	4498
2023 Q3	$21.2K	Buy	+1,300	New	+$25K	﹤0.01%	4384

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Walleye Trading's VRNA Position: Q4 2025 in Review

Walleye Trading sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 56,548 shares — an estimated $6.03M sold.

Walleye Trading first reported a position in VRNA in Q3 2023 and held it in 4 quarters. The position peaked at $6.03M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Walleye Trading reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Walleye Trading sold 56,548 Verona Pharma shares in Q4 2025, an estimated $6.03M.
Walleye Trading first reported a position in Verona Pharma in Q3 2023 and held it in 4 quarters.
Walleye Trading's Verona Pharma position peaked at $6.03M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.